Watson Settles with Barr Over Oxytrol
A unit of specialty pharmaceutical firm Watson Pharmaceuticals Inc. has struck a deal with Barr Pharmaceuticals Inc. that resolves patent litigation over Watson's Oxytrol and grants Barr a license to eventually...To view the full article, register now.
Already a subscriber? Click here to view full article